Revisiting Neos Therapeutics Before Key FDA Date

Biotech had a solid week last week as the overall market broke a two week losing streak.

Gilead's major acquisition this morning of Kite Pharma should get the sector off to a positive start this week.

All the other notable news, events and analyst ratings from across the sector are below. We also revisit Neos Therapeutics before its upcoming FDA decision date.

Back to news